Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ultragreen AiSGX:ULG -4.55%22 ROE % is 23.71% as of Jun. 2026, which is 53% below its 10-year median of 50.37. GuruFocus rates SGX:ULG with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 621 Healthcare Providers & Services companies, Ultragreen Ai ranks better than 95.81% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Ultragreen Ai's annualized net income for the quarter that ended in Jun. 2026 was $78.5 Mil. Ultragreen Ai's average Total Stockholders Equity over the quarter that ended in Jun. 2026 was $331.0 Mil. Therefore, Ultragreen Ai's annualized ROE % for the quarter that ended in Jun. 2026 was 23.71%.
The historical rank and industry rank for Ultragreen Ai's ROE % or its related term are showing as below:
SGX:ULG'
s ROE % Range Over the Past 10 Years
Min: 33.29 Med: 50.37 Max: 195.23
Current: 33.29
During the past 4 years, Ultragreen Ai's highest ROE % was 195.23%. The lowest was 33.29%. And the median was 50.37%.
SGX:ULG's ROE % is ranked better than 95.81% of 621
companies
in the Healthcare Providers & Services industry
Industry Median: 6.3
vs SGX:ULG: 33.29
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Jun. 2026) net income data. The Revenue data used here is two times the semi-annual (Jun. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Ultragreen Ai ROE % Related Terms
Ultragreen Ai ROE % Historical Data
* Premium members only.
The historical data trend for Ultragreen Ai's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Ultragreen Ai's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ultragreen Ai ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ultragreen Ai's ROE % distribution charts can be found below:
* The bar in red indicates where Ultragreen Ai's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Jun. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Ultragreen Ai (SGX:ULG) has a ROE % of 23.71% as of Jun. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Ultragreen Ai and its competitors. This is 53% below median its historical median of 50.37. Over the past decade, Ultragreen Ai's ROE % has ranged from 33.29 to 195.23. According to the industry distribution chart, Ultragreen Ai ranks #26 out of 621 companies in the Healthcare Providers & Services industry, placing it in the top 4.2%.
Is Ultragreen Ai's ROE % too high?
Ultragreen Ai's current ROE % of 23.71% is 53% below median its 10-year median of 50.37. Over the past 10 years, this metric has ranged from a low of 33.29 to a high of 195.23. The Healthcare Providers & Services industry median ROE % is 6.30. Ultragreen Ai's value of 23.71% is 276.3% above this industry median. Based on the distribution chart, Ultragreen Ai ranks #26 out of 621 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ultragreen Ai has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Ultragreen Ai's ROE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Ultragreen Ai ranks #26 out of 621 companies for ROE %. This places Ultragreen Ai in the top 4% of its industry — outperforming the majority of peers. The industry median ROE % is 6.30. Ultragreen Ai's value of 23.71% is 276.3% above this benchmark. Historically, Ultragreen Ai's own ROE % has ranged from 33.29 to 195.23 over the past decade. While the company's 10-year median is 50.37 vs. the industry median of 6.30, Ultragreen Ai has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 6.30, based on 621 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ultragreen Ai's current ROE % of 23.71% is 276.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Ultragreen Ai and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 6.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ultragreen Ai's current ROE % is 23.71%, which is 53% below median its own 10-year median of 50.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultragreen Ai stock overvalued right now?
Ultragreen Ai (SGX:ULG) has a current ROE % of 23.71%. The current ROE % is 23.71%, which is 53% below median its 10-year median of 50.37 and 276.3% above the Healthcare Providers & Services industry median of 6.30. Ultragreen Ai's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Ultragreen Ai (SGX:ULG), the current ROE % is 23.71% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ultragreen Ai Ltd is engaged in the sales of Indocyanine Green (ICG) pharmaceutical products and cardiology Picture Archiving and Communication System (PACS) software and associated products and services. It provides a fluorescence imaging ecosystem designed to support surgeons with real-time perfusion data and visualization capabilities. The company is organised into business units based on its products and services and operates in (a) the Diagnostic Green (DxG) - Americas segment; (b) the DxG - Rest of the World segment; and (c) the UltraLinQ segment. The company generates the maximum of its revenue from the the DxG - Rest of the World segment, which focuses on the sales of ICG vials and related pharmaceutical products.
22GF Score
Get the complete analysis for SGX:ULG
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:ULG has been successfully added to your 
